259 related articles for article (PubMed ID: 32630442)
1. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody.
Choi JR; Kim MJ; Tae N; Wi TM; Kim SH; Lee ES; Kim DH
Viruses; 2020 Jun; 12(6):. PubMed ID: 32630442
[TBL] [Abstract][Full Text] [Related]
2. Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.
Cembrola B; Ruzza V; Troise F; Esposito ML; Sasso E; Cafaro V; Passariello M; Visconte F; Raia M; Del Vecchio L; D'Alise AM; Cortese R; Scarselli E; Zambrano N; De Lorenzo C; Nicosia A
Biomed Res Int; 2019; 2019():6051870. PubMed ID: 31976323
[TBL] [Abstract][Full Text] [Related]
3. Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics.
Adler AS; Mizrahi RA; Spindler MJ; Adams MS; Asensio MA; Edgar RC; Leong J; Leong R; Johnson DS
MAbs; 2017; 9(8):1270-1281. PubMed ID: 28846506
[TBL] [Abstract][Full Text] [Related]
4. Comparative characterization of two monoclonal antibodies targeting canine PD-1.
Kocikowski M; Dziubek K; Węgrzyn K; Hrabal V; Zavadil-Kokas F; Vojtesek B; Alfaro JA; Hupp T; Parys M
Front Immunol; 2024; 15():1382576. PubMed ID: 38779661
[TBL] [Abstract][Full Text] [Related]
5. Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.
Li C; Zhang N; Zhou J; Ding C; Jin Y; Cui X; Pu K; Zhu Y
Cancer Immunol Res; 2018 Feb; 6(2):178-188. PubMed ID: 29217732
[TBL] [Abstract][Full Text] [Related]
6. Microbiota-Regulated Outcomes of Human Cancer Immunotherapy via the PD-1/PD-L1 Axis.
Patel J; Crawford JM
Biochemistry; 2018 Feb; 57(6):901-903. PubMed ID: 29350031
[No Abstract] [Full Text] [Related]
7. High-throughgput phage-display screening in array format.
Díez P; Jara-Acevedo R; González-González M; Casado-Vela J; Dasilva N; Lécrevisse Q; Bartolomé R; Claros JC; González A; López R; Orfao A; Fuentes M
Enzyme Microb Technol; 2015 Nov; 79-80():34-41. PubMed ID: 26320712
[TBL] [Abstract][Full Text] [Related]
8. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.
Tohidkia MR; Asadi F; Barar J; Omidi Y
BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946
[TBL] [Abstract][Full Text] [Related]
9. In vitro assay for the development of small molecule inhibitors targeting PD-1/PD-L1.
Zhai W; Zhou X; Du J; Gao Y
Methods Enzymol; 2019; 629():361-381. PubMed ID: 31727249
[TBL] [Abstract][Full Text] [Related]
10. Isolation of Antibody Binders to MISIIR from a Phage Display Library by Sorting.
Yuan AQ
Methods Mol Biol; 2020; 2108():147-157. PubMed ID: 31939178
[TBL] [Abstract][Full Text] [Related]
11. High-throughput reformatting of phage-displayed antibody fragments to IgGs by one-step emulsion PCR.
Liu Y; Gu M; Wu Y; Wang W; Wang R; Du M; Ma P; Zhou X; Wang Y; Cao Y; Zhang H
Protein Eng Des Sel; 2018 Nov; 31(11):427-436. PubMed ID: 31096267
[TBL] [Abstract][Full Text] [Related]
12. A Novel Dual Expression Platform for High Throughput Functional Screening of Phage Libraries in Product like Format.
Xiao X; Chen Y; Mugabe S; Gao C; Tkaczyk C; Mazor Y; Pavlik P; Wu H; Dall'Acqua W; Chowdhury PS
PLoS One; 2015; 10(10):e0140691. PubMed ID: 26468955
[TBL] [Abstract][Full Text] [Related]
13. Selection of a PD-1 blocking antibody from a novel fully human phage display library.
Peissert F; Plüss L; Giudice AM; Ongaro T; Villa A; Elsayed A; Nadal L; Dakhel Plaza S; Scietti L; Puca E; De Luca R; Forneris F; Neri D
Protein Sci; 2022 Dec; 31(12):e4486. PubMed ID: 36317676
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Antibody Selections by Combining Phage and Yeast Display.
Ferrara F; Soluri MF; Sblattero D
Methods Mol Biol; 2019; 1904():339-352. PubMed ID: 30539479
[TBL] [Abstract][Full Text] [Related]
15. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
[TBL] [Abstract][Full Text] [Related]
16. Round optimization for improved discovery of native bispecific antibodies.
Gueneau F; Ravn U; Fischer N
Methods; 2019 Feb; 154():51-59. PubMed ID: 30448477
[TBL] [Abstract][Full Text] [Related]
17. Generation of human and rabbit recombinant antibodies for the detection of Zearalenone by phage display antibody technology.
Sompunga P; Pruksametanan N; Rangnoi K; Choowongkomon K; Yamabhai M
Talanta; 2019 Aug; 201():397-405. PubMed ID: 31122440
[TBL] [Abstract][Full Text] [Related]
18. A single-step, high throughput, and highly reproducible method for measuring IgM quantity and avidity directly from fish serum via biolayer interferometry (BLI).
Li A; Harris RJ; Fry BG; Barnes AC
Fish Shellfish Immunol; 2021 Dec; 119():231-237. PubMed ID: 34626789
[TBL] [Abstract][Full Text] [Related]
19. Specific Cell Targeting by
Aljieli M; Rivière C; Lantier L; Moiré N; Lakhrif Z; Boussemart AF; Cnudde T; Lajoie L; Aubrey N; Ahmed EM; Dimier-Poisson I; Di-Tommaso A; Mévélec MN
Cells; 2024 Jun; 13(11):. PubMed ID: 38891106
[No Abstract] [Full Text] [Related]
20. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
